About PeptideFolio

PeptideFolio is a single-page ranking board for peptide-themed public equities and crypto tokens. We pull live prices, market caps, and 24-hour volume so you can see the whole peptide investing universe in one place.

Why this exists

The peptide thesis spans GLP-1 leaders (Eli Lilly, Novo Nordisk), telehealth distributors (Hims & Hers), specialty biotechs (Viking Therapeutics, PeptiDream), and a growing set of community-launched crypto tokens themed around individual research compounds (BPC-157, TB-500). No single source covered both sides of the universe at a glance — so we built one.

Who runs it

PeptideFolio is operated by members of the $WOLVERINE community on X. It is community-funded and intentionally minimal — no logins, no email capture, no paywall.

Conflict of interest disclosure

The operators hold $WOLVERINE tokens and may hold other listed tokens or equities. The $WOLVERINE token may appear in listings on this site. We do not accept payment for inclusion. Listing decisions are made on the criteria described in our Methodology.

Not advice

Nothing on PeptideFolio is investment, financial, medical, or tax advice. Peptides such as BPC-157 and TB-500 referenced on this site are research compounds and are not approved for human use in many jurisdictions. Always consult licensed professionals.

Contact

See our contact page for how to reach us, suggest a listing, or report data issues.